Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS INCMACK · Entity 95770 | Director | June 13, 2018 | June 15, 2018 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Director | April 23, 2019 | April 25, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MERRIMACK PHARMACEUTICALS INC
Report date June 13, 2018 · Filed June 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.67 · Expires 2028-06-12 | Direct | 7,000 |
Reported balance
After 2018-06-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-06-13 · Grant · Acquired 7,000 · Balance 7,000 F1: This option vests as to 1/4th of the total number of shares on 9/13/18 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 6/13/19, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 6/13/19). |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests as to 1/4th of the total number of shares on 9/13/18 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 6/13/19, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 6/13/19).
WELLS FARGO & COMPANY/MN
Report date April 23, 2019 · Filed April 25, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 24,362.0179 |
Reported balance
After 2019-04-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-04-23 · Grant · Acquired 3,802 · Balance 24,362.0179 F2: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F3: Deferred compensation shares payable in installments based upon director's election. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 2,465.967 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,465.967 F1: Total includes 21.896 shares acquired through Wells Fargo & Company's dividend reinvestment plan on March 1, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Total includes 21.896 shares acquired through Wells Fargo & Company's dividend reinvestment plan on March 1, 2019.
F2: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock.
F3: Deferred compensation shares payable in installments based upon director's election.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HESS CORP
Report date July 18, 2025 · Filed July 18, 2025
Section 16 reporting ended · disclosed 2025-07-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1.00 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-07-18 transaction · row 1
1 source rowRow 1 · 2025-07-18 · Disposition to issuer · Disposed 21,409.877 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated October 22, 2023 (as amended, the "merger agreement"), by and among Hess, Yankee Merger Sub Inc. ("Merger Sub") and Chevron Corporation ("Chevron"), at the effective time of the merger of Merger Sub with and into Hess on the closing date (the "Effective Time"), each outstanding share of common stock of Hess (except as otherwise specified in the merger agreement) was converted into the right to receive 1.025 (the "exchange ratio") shares of common stock of Chevron. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated October 22, 2023 (as amended, the "merger agreement"), by and among Hess, Yankee Merger Sub Inc. ("Merger Sub") and Chevron Corporation ("Chevron"), at the effective time of the merger of Merger Sub with and into Hess on the closing date (the "Effective Time"), each outstanding share of common stock of Hess (except as otherwise specified in the merger agreement) was converted into the right to receive 1.025 (the "exchange ratio") shares of common stock of Chevron.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2025 Filed Jul 18, 2025 16:27 UTC | HESS CORP HES · Entity 11019 | Disposition to issuerCommon Stock, $1.00 par value | 21,409.877 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-096942 · ownership.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated October 22, 2023 (as amended, the "merger agreement"), by and among Hess, Yankee Merger Sub Inc. ("Merger Sub") and Chevron Corporation ("Chevron"), at the effective time of the merger of Merger Sub with and into Hess on the closing date (the "Effective Time"), each outstanding share of common stock of Hess (except as otherwise specified in the merger agreement) was converted into the right to receive 1.025 (the "exchange ratio") shares of common stock of Chevron. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 16:45 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-036425 · ownership.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,409.877 Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 16:48 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 1,398 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-028710 · ownership.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,014.877 Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 16:42 UTC | HESS CORP HES · Entity 11019 | GiftCommon Stock, $1.00 par value | 13,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034367 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: Held by a previously reported grantor retained annuity trust. The reporting person is the trustee of the trust. Upon termination of the trust, 13,378 shares of common stock of the company were distributed to the reporting person's children. The remaining shares of common stock were distributed to the reporting person and continue to be reported in this Form 4 as directly owned. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 19:48 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 1,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017362 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Note Disclosed balance after: 31,925.069 F1 · balance_after: Reflects shares acquired pursuant to a dividend reinvestment plan in accordance with Ruly 16a-111. F2 · ownership.nature: These shares are held in a grantor retained annuity trust. The reporting person is the trustee of the trust. Read SEC document |
| March 06, 2022 Filed Mar 8, 2022 21:12 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 1,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017406 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Note Disclosed balance after: 30,216.972 F1 · balance_after: Reflects shares acquired pursuant to a dividend reinvestment plan in accordance with Rule 16a-11. F2 · ownership.nature: Shares previously reported as directly beneficially owned and subsequently were contributed to a grantor retained annuity trust. The reporting person is the trustee of the trust. Read SEC document |
| March 06, 2021 Filed Mar 9, 2021 19:40 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 2,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-019278 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,852 Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 17:08 UTC | HESS CORP HES · Entity 11019 | PurchaseCommon Stock, $1.00 par value | 503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-017758 · doc4.xml · nonDerivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,520 Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 17:08 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 3,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-017758 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 18:23 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,802 | $47.35 | $180,024.70 |
DisclosureSEC source: 0001127602-19-016189 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,362.0179 Underlying: Common Stock, $1 2/3 Par Value · 3,802 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F3 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F3 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:43 UTC | HESS CORP HES · Entity 11019 | PurchaseCommon Stock, $1.00 par value | 442 | $56.74 | $25,079.08 |
DisclosureSEC source: 0001209191-19-018148 · doc4.xml · nonDerivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,139 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:43 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 2,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-018148 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,697 Read SEC document |
| June 25, 2018 Filed Feb 12, 2019 19:47 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | OtherCommon Stock, $1 2/3 Par Value | 0.688 | $54.03 | $37.17 |
DisclosureSEC source: 0001127602-19-005306 · form5.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,444.071 F1 · balance_after: Total includes 53.132 shares acquired through Wells Fargo & Company's dividend reinvestment plan from June 1, 2018 through December 1, 2018. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 16:34 UTC | MERRIMACK PHARMACEUTICALS INC MACK · Entity 95770 | GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $9.67 | $0.00 |
DisclosureSEC source: 0001209191-18-038080 · doc4.xml · derivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2028-06-12 F1 · derivative.exercise_date: This option vests as to 1/4th of the total number of shares on 9/13/18 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 6/13/19, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 6/13/19). Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 16:19 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,325 | $52.51 | $174,595.75 |
DisclosureSEC source: 0001127602-18-015300 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,926.9162 Underlying: Common Stock, $1 2/3 Par Value · 3,325 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Company common stock. F3 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F3 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 16:19 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock, $1 2/3 Par Value | 103 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015300 · form4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,390.251 F1 · balance_after: Total includes 137.251 shares acquired through Wells Fargo & Company's (the "Company") dividend reinvestment plan from December 1, 2013 through March 1, 2018. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 18:30 UTC | HESS CORP HES · Entity 11019 | PurchaseCommon Stock, $1.00 par value | 516 | $48.48 | $25,015.68 |
DisclosureSEC source: 0001209191-18-018267 · doc4.xml · nonDerivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,054 Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 18:30 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 3,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-018267 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,538 Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 16:49 UTC | MERRIMACK PHARMACEUTICALS INC MACK · Entity 95770 | GrantStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $13.99 | $0.00 |
DisclosureSEC source: 0001209191-17-053006 · doc4.xml · derivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-09-12 F1 · derivative.exercise_date: This option is fully vested. Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 17:39 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,300 | $54.56 | $180,048.00 |
DisclosureSEC source: 0001127602-17-015674 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,133.9879 Underlying: Common Stock, $1 2/3 Par Value · 3,300 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:56 UTC | HESS CORP HES · Entity 11019 | PurchaseCommon Stock, $1.00 par value | 484 | $51.71 | $25,027.64 |
DisclosureSEC source: 0001209191-17-016860 · doc4.xml · nonDerivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,444 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:56 UTC | HESS CORP HES · Entity 11019 | GrantCommon Stock, $1.00 par value | 2,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016860 · doc4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,960 Read SEC document |
| May 03, 2016 Filed May 4, 2016 17:00 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | PurchaseCommon Stock, $1 2/3 Par Value | 2,000 | $49.97 | $99,940.00 |
DisclosureSEC source: 0001127602-16-051003 · form4.xml · nonDerivative · entry 1 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Read SEC document |
| April 26, 2016 Filed Apr 28, 2016 18:51 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,535 | $50.92 | $180,002.20 |
DisclosureSEC source: 0001127602-16-050165 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,476.6161 Underlying: Common Stock, $1 2/3 Par Value · 3,535 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 28, 2015 Filed Apr 30, 2015 17:59 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,249 | $55.41 | $180,027.09 |
DisclosureSEC source: 0001127602-15-015636 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,691.4795 Underlying: Common Stock, $1 2/3 Par Value · 3,249 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 29, 2014 Filed Apr 30, 2014 18:07 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,235 | $49.47 | $160,035.45 |
DisclosureSEC source: 0001127602-14-015587 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300.15 Underlying: Common Stock, $1 2/3 Par Value · 3,235 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| October 22, 2013 Filed Oct 24, 2013 15:28 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 2,038 | $42.94 | $87,511.72 |
DisclosureSEC source: 0001127602-13-029696 · form4.xml · derivative · entry 2 Quigley James H. · CIK 0001554331 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,038 Underlying: Common Stock, $1 2/3 Par Value · 2,038 shares Expires not disclosed F1 · derivative.exercise_price: Conversion price is 1-for-1. F2 · derivative.exercise_date: Deferred compensation shares payable in installments depending upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments depending upon director's election. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.